Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.22.2.2
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Revenue:        
Products, services, other $ 498,137 $ 608,927 $ 978,137 $ 1,168,801
Total revenue 498,137 608,927 978,137 1,168,801
Costs and expenses:        
Cost of products and services 302,141 286,660 616,504 512,935
Research and development 172,726 256,507 454,315 556,450
Selling and marketing 129,434 92,813 195,896 186,141
General and administrative 795,466 619,286 1,699,351 1,634,716
Total operating costs and expenses 1,399,767 1,255,266 2,966,066 2,890,242
Operating loss (901,630) (646,339) (1,987,929) (1,721,441)
Other (expense) income:        
Interest expense, net (1,835,589) (3,526,141) (4,414,750) (8,194,205)
Unrealized (loss) gain on investment in equity securities (18,510) (134,477) 628 (242,380)
Loss on extinguishment of liabilities (165,277) (498,226) (755,127) (1,223,385)
Other income 4,668 60,012 1,155 58,653
Total other expense (2,014,708) (4,098,832) (5,168,094) (9,601,317)
Net loss (2,916,338) (4,745,171) (7,156,023) (11,322,758)
Deemed dividends on beneficial conversion feature (57,884)
Preferred stock dividends (431,708) (404,171) (863,857) (807,386)
Net loss attributable to common stockholders $ (3,348,046) $ (5,149,342) $ (8,019,880) $ (12,188,028)
Basic and diluted net loss per share attributable to common stockholders $ (0.32) $ (0.90) $ (0.80) $ (2.29)
Weighted average common stock shares outstanding used in the basic and diluted net loss per share calculation 10,462,520 5,748,711 10,029,068 5,312,172